WBB Securities

WBB Securities, LLC

Independent broker-dealer, investment bank and sell-side research firm based in Cranford, New Jersey, focused on biotechnology, pharmaceutical and medical device companies.

Company history

Steve Brozak, who previously held positions at Salomon Brothers, Dean Witter, Cowen & Company and Alex. Brown & Sons and is a retired U.S. Marine Corps lieutenant colonel, co-founded WBB Securities in 2001. The firm is an SEC-registered broker-dealer and a state-registered investment adviser with offices in New Jersey, New York and California, and in September 2016 it added an asset-management arm that launched a long/short healthcare fund.

  1. 2001Steve Brozak co-founds WBB Securities
  2. 2016Adds asset-management arm and long/short healthcare fund

Research

Research concentrates on life sciences companies, with Brozak as senior analyst; he was named a 2013 StarMine Top Stock Picker among pharmaceutical analysts in the Thomson Reuters awards and 'Best on the Street' for medical equipment and supplies by The Wall Street Journal. Ratings run Strong Buy, Buy, Speculative Buy (aggressive accounts only), Core Holding, Hold, Sell and Sell Short, with 12-month price targets.

Coverage12M

Stocks
3
Ratings
3
Price targets
0
Upgrades
0
Downgrades
1
Initiations
1
Reiterations
1
  • Positive67%2
  • Neutral0%0
  • Negative33%1

Sectors

  • Health Care100%

Ratings

  • Strong Buy33%
  • Sell33%
  • Speculative Buy33%

Listing

  • United States100%

Activity24M

RatingsPrice targets2
Oct 2024 · Ratings 0 · Price targets 0Nov 2024 · Ratings 0 · Price targets 0Dec 2024 · Ratings 0 · Price targets 0Jan 2025 · Ratings 0 · Price targets 0Feb 2025 · Ratings 0 · Price targets 0Mar 2025 · Ratings 0 · Price targets 0Apr 2025 · Ratings 1 · Price targets 0May 2025 · Ratings 0 · Price targets 0Jun 2025 · Ratings 0 · Price targets 0Jul 2025 · Ratings 0 · Price targets 0Aug 2025 · Ratings 0 · Price targets 0Sep 2025 · Ratings 1 · Price targets 0Oct 2025 · Ratings 1 · Price targets 0Nov 2025 · Ratings 0 · Price targets 0Dec 2025 · Ratings 0 · Price targets 0Jan 2026 · Ratings 0 · Price targets 0Feb 2026 · Ratings 0 · Price targets 0Mar 2026 · Ratings 0 · Price targets 0Apr 2026 · Ratings 0 · Price targets 0May 2026 · Ratings 0 · Price targets 0Jun 2026 · Ratings 0 · Price targets 0Jul 2026 · Ratings 0 · Price targets 0Aug 2026 · Ratings 0 · Price targets 0Sep 2026 · Ratings 2 · Price targets 0
Oct '24Oct '25Sep '26

Most covered24M

StockRatingTargetActionsLast action
CELUCelularity Inc.Buy1Sep 9
MRKRMarker Therapeutics, Inc.Strong Buy1Apr 1
OMEROmeros CorporationStrong Buy1Oct 15
TTRXTurn Therapeutics Inc.Sell1Sep 14
VOGXVogenx Inc.Speculative Buy1Sep 2

Recent actions

StockRating actionRatingDate
Turn Therapeutics Inc.TTRXDowngradeHoldSellSep 14
Vogenx Inc.VOGXInitiateSpeculative BuySep 2
Omeros CorporationOMERReiterateStrong BuyOct 15, 2025
Celularity Inc.CELUUpgradeHoldBuySep 9, 2025
Marker Therapeutics, Inc.MRKRReiterateStrong BuyApr 1, 2025
Omeros CorporationOMERReiterateStrong BuyJun 18, 2021
RedHill Biopharma Ltd.RDHLDowngradeStrong BuyBuyMay 28, 2021
SCYNEXIS, Inc.SCYXReiterateBuyNov 25, 2020
Arcturus Therapeutics Holdings Inc.ARCTReiterateBuyNov 25, 2020
Arcturus Therapeutics Holdings Inc.ARCTDowngradeStrong BuyHoldJun 9, 2020
RedHill Biopharma Ltd.RDHLUpgradeBuyStrong BuyJul 12, 2019
Marker Therapeutics, Inc.MRKRUpgradeBuyStrong BuyMar 29, 2019

References

  1. Steve Brozak - Wikipediaen.wikipedia.org
  2. WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026wbbsec.com
  3. The Team - WBB Securitieswbbsec.com
  4. WBB Securities report on Cidara Therapeutics with rating legend (2023)wbbsec.com
  5. WBB SECURITIES, LLC - FINRA BrokerCheckbrokercheck.finra.org